NCT00146055View on ClinicalTrials.gov

Low-Intensity Preparation and Allogeneic Transplant in Patients With Cancers of the Blood

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 31, 2000

Primary Completion Date

November 30, 2004

Study Completion Date

October 31, 2007

Conditions
Myeloma, Plasma-CellLymphoma, MalignantMyeloproliferative DisordersMyelodysplastic SyndromesWaldenstrom's Macroglobulinemia
Interventions
PROCEDURE

Reduced intensity conditioning with allogeneic transplant

Trial Locations (1)

48109

The University of Michigan, Ann Arbor

All Listed Sponsors
lead

University of Michigan Rogel Cancer Center

OTHER

NCT00146055 - Low-Intensity Preparation and Allogeneic Transplant in Patients With Cancers of the Blood | Biotech Hunter | Biotech Hunter